Phase II clinical trial results of Liposome-Entrapped Paclitaxel announced

[News]

NeoPharm, Inc. today announced the results of a Phase II clinical trial of Liposome-Entrapped Paclitaxel (LEP) an active component of Taxol®. This multicenter, open-label trial of LEP was conducted at 5 centers in India.

More... (http://www.news-medical.net/news/20100107/Phase-II-clinical-trial-results-of-Liposome-Entrapped-Paclitaxel-announced.aspx)